Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank78
3Y CAGR+1.3%
5Y CAGR+11.2%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+1.3%/yr
vs +37.2%/yr prior
5Y CAGR
+11.2%/yr
Recent deceleration
Acceleration
-36.0pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$136.32M-58.9%
2024$331.65M+50.1%
2023$221.02M+68.3%
2022$131.29M+56.9%
2021$83.69M+4.3%
2020$80.25M+52.0%
2019$52.81M+42.7%
2018$37.01M+33.7%
2017$27.68M+47.1%
2016$18.81M-